---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-003240"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2026-04-07T23:59:59+00:00"
generated_at: "2026-05-15T07:00:58.960313+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ZEO ScientifiX selected as qualified team for XPRIZE Healthspan $101M competition semi-finals

## Summary
- Advancing to semi-finals of XPRIZE Healthspan; aims to develop therapeutics restoring muscle, cognitive, and immune function by 10-20 years in persons aged 65-80.
- Assembled multidisciplinary team: Dr. Shapiro (CMO), Elizabeth Parrish (BioViva), Dr. Andrews (telomere biology), Dr. Kennedy (Buck Institute), and others.
- Focus on extracellular vesicle (exosome) therapeutics and next-generation delivery systems targeting aging and inflammation biology.
- Company operates labs at Nova Southeastern University; recently appointed as A4M regenerative medicine educational partner.

## SEC filing metadata
- accession: 0001829126-26-003240
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2026-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912626003240/0001829126-26-003240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912626003240/zeoscientifix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-003240
- JSON: https://secwatch.observer/filing/0001829126-26-003240.json
- Plain text: https://secwatch.observer/filing/0001829126-26-003240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.